CRP and neoplasm: The main diagnostic characteristic of IHCA, namely activation of the JAK-STAT-pathway, can be immunohistochemically proven by a homogenous, non-mosaic-like expression of C-reactive protein (CRP) and Serum amyloid A (SAA) in all tumor cells (Figure 3E).